We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
-10.7%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$11.7B
AUM Growth
-$3.17B
Cap. Flow
-$1.15B
Cap. Flow %
-9.88%
Top 10 Hldgs %
46.25%
Holding
136
New
17
Increased
36
Reduced
23
Closed
34

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$440M
2
IQV icon
IQVIA
IQV
+$269M
3
AGN
Allergan plc
AGN
+$247M
4
GD icon
General Dynamics
GD
+$183M
5
FIS icon
Fidelity National Information Services
FIS
+$158M

Top Sells

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$793M
2
MDCO
Medicines Co
MDCO
+$282M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$236M
4
SPGI icon
S&P Global
SPGI
+$175M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 52.14%
2 Communication Services 12.39%
3 Technology 10.92%
4 Industrials 5.44%
5 Financials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRMR icon
101
Larimar Therapeutics
LRMR
$434M
– –
-150,697
Closed -$2.01M
OPK icon
102
Opko Health
OPK
$1.1B
– –
-2,500,000
Closed -$3.67M
PTCT icon
103
PTC Therapeutics
PTCT
$5.83B
– –
-726,986
Closed -$34.9M
RCKT icon
104
Rocket Pharmaceuticals
RCKT
$385M
– –
-354,082
Closed -$8.06M
SMH icon
105
PUT
VanEck Semiconductor ETF
SMH
$68.6B
– –
-5,010,000
Closed -$354M
SPGI icon
106
S&P Global
SPGI
$127B
– –
-640,382
Closed -$175M
SRPT icon
107
CALL
Sarepta Therapeutics
SRPT
$1.98B
– –
-400,000
Closed -$51.6M
XGN icon
108
Exagen
XGN
$192M
– –
-577,699
Closed -$14.7M
RETA
109
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-75,000
Closed -$15.3M
APTX
110
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-408,549
Closed -$1.4M
OYST
111
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-230,800
Closed -$5.64M
CCXI
112
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-1,500,000
Closed -$59.3M
GBT
113
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-750,000
Closed -$59.6M
TIF
114
DELISTED
Tiffany & Co.
TIF
– –
-225,000
Closed -$30.1M
LVGO
115
DELISTED
Livongo Health, Inc. Common Stock
LVGO
– –
-600,000
Closed -$15M
LOGM
116
DELISTED
LogMein, Inc.
LOGM
– –
-130,241
Closed -$11.2M
AXE
117
DELISTED
Anixter International Inc
AXE
– –
-917,893
Closed -$84.5M
MLNX
118
DELISTED
Mellanox Technologies, Ltd.
MLNX
– –
-270,000
Closed -$31.6M
S
119
DELISTED
Sprint Corporation
S
– –
-3,200,000
Closed -$16.7M
INST
120
DELISTED
Instructure, Inc.
INST
– –
-620,000
Closed -$29.9M
ZAYO
121
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-6,820,000
Closed -$236M
WCG
122
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-2,400,000
Closed -$793M
ARQL
123
DELISTED
Arqule Inc
ARQL
– –
-2,520,000
Closed -$50.3M
BOLD
124
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-1,190,000
Closed -$71.2M
MDCO
125
DELISTED
Medicines Co
MDCO
– –
-3,315,000
Closed -$282M
2 3 4
5
6

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2020 Portfolio in Review

As of Q1 2020, Thomas Steyer held 136 positions worth $11.7B, down 21% from $14.8B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Thomas Steyer withdrew a net $1.15B in Q1 2020, closing 34 positions and reducing 23 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $793M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 47% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Thomas Steyer opened a new position in Centene worth $431M.

  • Thomas Steyer's largest Q1 2020 buy was Centene: 7,250,000 shares worth $431M.
  • Thomas Steyer added most to IQVIA in Q1 2020, an estimated $269M increase.
  • Thomas Steyer's biggest Q1 2020 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $104M.
  • Thomas Steyer fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $793M.
  • Thomas Steyer's ten largest holdings make up 46% of its $11.7B portfolio in Q1 2020.
  • Thomas Steyer opened 17 new positions and closed 34 in Q1 2020.
  • Thomas Steyer's portfolio value fell 21% quarter-over-quarter to $11.7B.

Based on Farallon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.